I-4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4 Lenvatinib Mesylate Intermediate Purity>98.0% (HPLC)
I-Ruifu Chemical Supply Lenvatinib Mesylate Intermediate with High Purity
Lenvatinib Mesylate CAS 857890-39-2
I-4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9
I-Desquinolinyl Lenvatinib;I-1-(2-Chloro-4-Hydroxyphenyl)-3-Cyclopropylurea CAS 796848-79-8
Methyl 7-Methoxy-4-Oxo-1,4-Dihydroquinoline-6-Carboxylate CAS 205448-65-3
Methyl 4-Amino-2-Methoxybenzoate CAS 27492-84-8
5-(Methoxymethylene) -2,2-Dimethyl-1,3-Dioxane-4,6-Dione CAS 15568-85-1
I-4-Amino-3-Chlorophenol CAS 17609-80-2
I-4-Amino-3-Chlorophenol Hydrochloride CAS 52671-64-4
Methyl 4-Chloro-7-Methoxyquinoline-6-Carboxylate CAS 205448-66-4
Igama leMchiza | I-4-Amino-3-Chlorophenol Hydrochloride |
Izithethantonye | I-2-Chloro-4-Hydroxyaniline Hydrochloride |
Inombolo yeCAS | 618-89-3 |
Inombolo yeCAT | RF-PI1969 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C6H6ClNO·HCl |
Ubunzima beMolekyuli | 180.03 |
Indawo yokunyibilika | 254.0~256.0℃(dec.)(lit.) |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | I-Brown Solid Powder |
Ubunyulu / Indlela yokuHlalutya | >98.0% (HPLC) |
Ubunyulu / Indlela yokuHlalutya | 97.5 ~ 102.5% (Titration ngu-AgNO3) |
Ilahleko ekomisweni | <0.50% |
Intsalela kwi-Ignition | <0.30% |
Ukungcola ngokupheleleyo | <2.00% |
I-Infrared Spectrum | Iyahambelana noLwakhiwo |
Proton NMR Spectrum | Iyahambelana noLwakhiwo |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Umbindi weLenvatinib Mesylate (CAS: 857890-39-2) |
Iphakheji: Ibhotile, ingxowa yefoyile yeAluminiyam, 25kg/Igubu lekhadibhodi, okanye ngokwemfuno yomthengi
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ukukhanya kunye nokufuma
I-4-Amino-3-Chlorophenol Hydrochloride (CAS: 52671-64-4) iphakathi kweLenvatinib Mesylate (CAS: 857890-39-2).ILenvatinib (igama lokurhweba elithi Lenvima) lichiza elichasene nomhlaza kunyango lweentlobo ezithile zomhlaza wedlala lengqula, kwaye okunokwenzeka nakwezinye iimhlaza.I-Lenvatinib isetyenziselwa unyango lomhlaza we-thyroid owahlukileyo onokuthi ubuyele kwindawo yendawo okanye i-ormetastatic, i-progressive, kwaye ayizange iphendule unyango nge-iodine ye-radioactive (i-radioiodine) .I-LENVATINIB iyeza elijolise kwiiprotheni kwiiseli zomhlaza kwaye liyeke ukukhula kweeseli zomhlaza.Isetyenziselwa ukunyanga umhlaza wegilo kunye nomhlaza wezintso.Thelekisa i-kinase inhibitors.I-Lenvatinib i-multi-target inhibitor ye-VEGFR2 kunye ne-VEGFR3 kunye ne-IC50 ye-4 nM kunye ne-5.2 nM, ngokulandelanayo.